Will a Phase III hantavirus vaccine trial report positive results in 2026?

Started
Ends
00
MTH
00
DAY
00
HRS
00
MIN
00
SEC

About this Market

Measures whether researchers announce a successful hantavirus vaccine trial globally.

1 traders/$1 total volume
UserSideAmountDate
novaangel
YES$1 USDC

Discussion

0 comments
CU

No discussion yet.